Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an Anticonvulsant (pyrrolidine derivative) presented as a tablet for oral use. It is used to manage partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an anticonvulsant indicated for several seizure types.

- Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes. - Myoclonic seizures: decreases occurrence of rapid muscle jerks.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate head pain. - Irritability: mood changes or increased agitation. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood or behavior changes: depression, suicidal thoughts, or aggression. - Blood disorders: low white blood cells or platelets. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Levetiracetam should be used with caution in specific clinical situations.

- Renal function: adjust use in patients with impaired kidney function. - Hepatic function: monitor liver disease as clearance may be affected. - Pregnancy: safety not established; use only if benefit outweighs risk. - Concomitant CNS depressants: may increase sedation or dizziness. - Driving and machinery: caution due to possible dizziness or drowsiness. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenytoin: may decrease efficacy of levetiracetam. - Phenobarbital: can lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Sedative antihistamines: increase drowsiness. - Opioids: potential additive sedation.